MiR-34 activity is modulated through 5′-end phosphorylation in response to DNA damage

Nature Communications

Volumn 7, Issue , 2016, Pages

  Salzman, David W ^a   Nakamura, Kotoka ^b   Nallur, Sunitha ^a   Dookwah, Michelle T ^a   Metheetrairut, Chanatip ^c   Slack, Frank J ^c,d   Weidhaas, Joanne B ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c YALE UNIVERSITY   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' PHOSPHATE; ARGONAUTE 2 PROTEIN; ATM PROTEIN; ATR PROTEIN; CLP1 PROTEIN; DICER; DROSHA PROTEIN; EXONUCLEASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MICRORNA; MICRORNA 19; MICRORNA 24; MICRORNA 31; MICRORNA 34; MICRORNA 34A; MICRORNA 34B; MICRORNA 34C; PHOSPHATE; PROTEIN; PROTEIN P53; RNA PRECURSOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIMENTIN; ARGONAUTE PROTEIN; CLP1 PROTEIN, HUMAN; EIF2C2 PROTEIN, HUMAN; MIRN34 MICRORNA, HUMAN; NUCLEAR PROTEIN; PHOSPHOTRANSFERASE; TRANSCRIPTION FACTOR;

CELLS AND CELL COMPONENTS; DAMAGE; DNA; GENE EXPRESSION; GENETIC ANALYSIS; PHOSPHATE; TUMOR;

ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; GENE REPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NORTHERN BLOTTING; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; RADIATION EXPOSURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WILD TYPE; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHOSPHORYLATION;

ARGONAUTE PROTEINS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CELL LINE; DNA DAMAGE; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; NUCLEAR PROTEINS; PHOSPHORYLATION; PHOSPHOTRANSFERASES; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84961770712     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10954     Document Type: Article

References (43)

1. Newman, M. A., Hammond, S. M. Emerging paradigms of regulated microRNA processing. Genes Dev. 24, 1086-1092 (2010).
2. Krol, J., Loedige, I., Filipowicz, W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 11, 597-610 (2010).
3. Kelnar, K., Peltier, H., Leatherbury, N., Stoudemire, J., Bader, A. G. Quantification of therapeutic miRNA mimics in whole blood from nonhuman primates. Anal. Chem. 86, 1534-1542 (2014).
4. Chang, T. C. et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell 26, 745-752 (2007).
5. He, L. et al. A microRNA component of the p53 tumour suppressor network. Nature 447, 1130-1134 (2007).
6. Raver-Shapira, N. et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell 26, 731-743 (2007).
7. Hermeking, H. The miR-34 family in cancer and apoptosis. Cell Death Differ. 17, 193-199 (2009).
8. Miska, E. A. et al. Most Caenorhabditis elegans microRNAs are individually not essential for development or viability. PLoS Genet. 3, e215 (2007).
9. Park, C. Y. et al. A resource for the conditional ablation of microRNAs in the mouse. Cell Rep. 1, 385-391 (2012).
10. Leung, A. K., Sharp, P. A. MicroRNA functions in stress responses. Mol. Cell 40, 205-215 (2010).
11. Kato, M. et al. The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells. Oncogene 28, 2419-2424 (2009).
12. Burke, S., Hammell, M., Ambros, V. Robust distal tip cell pathfinding in the face of temperature stress is ensured by two conserved microRNAs in Caenorhabditis elegans. Genetics 200, 1201-1218 (2015).
13. Bandi, N., Vassella, E. miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner. Mol. Cancer 10, 55 (2011).
14. Lal, A. et al. Capture of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signaling. PLoS Genet. 7, e1002363 (2011).
15. Ji, Q. et al. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer 8, 266 (2008).
16. Bommer, G. T. et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol. 17, 1298-1307 (2007).
17. Hutvagner, G. et al. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293, 834-838 (2001).
18. Basyuk, E., Suavet, F., Doglio, A., Bordonne, R., Bertrand, E. Human let-7 stem-loop precursors harbor features of RNase III cleavage products. Nucleic Acids Res. 31, 6593-6597 (2003).
19. Zhang, H., Kolb, F. A., Jaskiewicz, L., Westhof, E., Filipowicz, W. Single processing center models for human Dicer and bacterial RNase III. Cell 118, 57-68 (2004).
20. Rivas, F. V. et al. Purified Argonaute2 and an siRNA form recombinant human RISC. Nat. Struct. Mol. Biol. 12, 340-349 (2005).
21. Ma, J. B. et al. Structural basis for 5'-end-specific recognition of guide RNA by the A. fulgidus Piwi protein. Nature 434, 666-670 (2005).
22. Schirle, N. T., MacRae, I. J. The crystal structure of human Argonaute2. Science 336, 1037-1040 (2012).
23. Elkayam, E. et al. The structure of human argonaute-2 in complex with miR-20a. Cell 150, 100-110 (2012).
24. Shiloh, Y. ATM and ATR: networking cellular responses to DNA damage. Curr. Opin. Genet. Dev. 11, 71-77 (2001).
25. Jackson, S. P., Bartek, J. The DNA-damage response in human biology and disease. Nature 461, 1071-1078 (2009).
26. Canman, C. E. et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281, 1677-1679 (1998).
27. Ziv, Y. et al. Recombinant ATM protein complements the cellular A-T phenotype. Oncogene 15, 159-167 (1997).
28. Weitzer, S., Martinez, J. The human RNA kinase hClp1 is active on 3' transfer RNA exons and short interfering RNAs. Nature 447, 222-226 (2007).
29. Weidhaas, J. B. et al. MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res. 67, 11111-11116 (2007).
30. Weidhaas, J. B., Eisenmann, D. M., Holub, J. M., Nallur, S. V. A Caenorhabditis elegans tissue model of radiation-induced reproductive cell death. Proc. Natl Acad. Sci. USA 103, 9946-9951 (2006).
31. Weidhaas, J. B., Eisenmann, D. M., Holub, J. M., Nallur, S. V. A conserved RAS/mitogen-activated protein kinase pathway regulates DNA damage-induced cell death postirradiation in Radelegans. Cancer Res. 66, 10434-10438 (2006).
32. Zhang, X., Wan, G., Berger, F. G., He, X., Lu, X. The ATM kinase induces microRNA biogenesis in the DNA damage response. Mol. Cell 41, 371-383 (2012).
33. O'Connell, R. M., Rao, D. S., Baltimore, D. microRNA regulation of inflammatory responses. Annu. Rev. Immunol. 30, 295-312 (2012).
34. Nishida, N., Mimori, K., Mori, M., Calin, G. A. EGFR gets in the way of microRNA biogenesis. Cell Res. 23, 1157-1158 (2013).
35. Shen, J. et al. EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. Nature 497, 383-387 (2013).
36. Crosby, M. E., Kulshreshtha, R., Ivan, M., Glazer, P. M. MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res. 69, 1221-1229 (2009).
37. Kim, Y., Kim, V. N. MicroRNA factory: RISC assembly from precursor microRNAs. Mol. Cell 46, 384-386 (2012).
38. Kawamata, T., Tomari, Y. Making RISC. Trends Biochem. Sci. 35, 368-376 (2010).
39. Wan, G. et al. DNA Damage-induced nuclear export of precursor microRNAs is regulated by the ATM-AKT pathway. Cell Rep. 3, 2100-2112 (2013).
40. Xhemalce, B., Robson, S., Kouzarides, T. Human RNA methyltransferase BCDIN3D regulates microRNA processing. Cell 151, 278-288 (2012).
41. Xie, M. et al. Mammalian 5'-capped microRNA precursors that generate a single microRNA. Cell 155, 1568-1580 (2013).
42. Rio, D. C., Ares, Jr. M., Hannon, G. J., Nilsen, T. W. Purification of RNA using TRIzol (TRI reagent). Cold Spring Harb. Protoc. 2010, pdb prot5439 (2010).
43. Meister, G. et al. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol. Cell 15, 185-197 (2004).